Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

53.84
-0.1000-0.19%
Post-market: 53.72-0.1200-0.22%18:55 EDT
Volume:3.03M
Turnover:164.53M
Market Cap:109.34B
PE:14.41
High:54.75
Open:54.23
Low:53.79
Close:53.94
52wk High:61.70
52wk Low:32.38
Shares:2.03B
Float Shares:1.95B
Volume Ratio:0.59
T/O Rate:0.16%
Dividend:1.75
Dividend Rate:3.25%
EPS(TTM):3.74
EPS(LYR):3.74
ROE:43.31%
ROA:9.79%
PB:5.03
PE(LYR):14.41

Loading ...

GlaxoSmithKline Projects Slower Revenue Growth for 2026

Deep News
·
Feb 04

GSK's New CEO to Deliver First Results -- Earnings Preview

Dow Jones
·
Feb 03

Wave Life Sciences price target raised to $50 from $47 at Clear Street

TIPRANKS
·
Feb 03

GSK Rises Monday, Outperforms Market

Dow Jones
·
Feb 03

GSK Rises Friday, Outperforms Market

Dow Jones
·
Jan 31

GSK Advances Shigella Vaccine Program With Completed Phase 2 Trial in African Infants

TIPRANKS
·
Jan 31

GSK’s Long-Term Nucala Study in EGPA Nears the Finish Line: What Investors Should Know

TIPRANKS
·
Jan 31

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Jan 30

Update: European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading

MT Newswires Live
·
Jan 30

GSK Rallies Thursday, Outperforms Market

Dow Jones
·
Jan 30

GSK Falls Wednesday, Underperforms Market

Dow Jones
·
Jan 29

Medicare is about to start negotiating the prices of medications administered by doctors

Dow Jones
·
Jan 28

European Pharmaceutical Stocks Follow U.S. Peers Down -- Market Talk

Dow Jones
·
Jan 28

Earning Preview: GlaxoSmithKline PLC Q4 revenue is expected to increase by 17.57%, and institutional views are bullish

Earnings Agent
·
Jan 28

GSK’s Benlysta Real‑World Study Nears the Finish Line: What Investors Should Watch

TIPRANKS
·
Jan 28

GlaxoSmithKline (GSK) Receives a New Rating from Bank of America Securities

TIPRANKS
·
Jan 27

GSK Rises Monday, Outperforms Market

Dow Jones
·
Jan 27

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Jan 27

GSK Buyout Turns Volatile RAPT Into Food Allergy Cash-Out Story

Simply Wall St.
·
Jan 24

GSK Says China Approves Trelegy Ellipta for Adults With Uncontrolled Asthma

MT Newswires Live
·
Jan 23